These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1798965)

  • 1. Effect of chlorobutanol and DDAVP on whole blood aggregation/clotting.
    Stewart MW; Gordon PA
    Thromb Res; 1991 Dec; 64(6):757-62. PubMed ID: 1798965
    [No Abstract]   [Full Text] [Related]  

  • 2. Is the pro-adhesive activity of plasma von Willebrand factor counteracted by a physiological inhibitor of platelet adhesiveness?
    Porta M; Cagliero E; Kohner EM
    Clin Sci (Lond); 1982 Feb; 62(2):239-42. PubMed ID: 6797774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Availability of endothelial von Willebrand factor and platelet function in diabetic patients infused with a vasopressin analogue.
    Porta M
    Diabetologia; 1982 Nov; 23(5):452-5. PubMed ID: 6816652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of effect of 1-desamino-8-D-arginine vasopressin on direct adhesion of platelets to collagen.
    Ghosh S; Rao AK
    Thromb Res; 1993 Jun; 70(5):417-22. PubMed ID: 7690994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet aggregation induced by 1-desamino-8-D-arginine vasopressin (DDAVP) in Type IIB von Willebrand's disease.
    Holmberg L; Nilsson IM; Borge L; Gunnarsson M; Sjörin E
    N Engl J Med; 1983 Oct; 309(14):816-21. PubMed ID: 6412139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of desmopressin on platelet function: a selective enhancement of procoagulant COAT platelets in patients with primary platelet function defects.
    Colucci G; Stutz M; Rochat S; Conte T; Pavicic M; Reusser M; Giabbani E; Huynh A; Thürlemann C; Keller P; Alberio L
    Blood; 2014 Mar; 123(12):1905-16. PubMed ID: 24443440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Desmopressin (DDAVP) improves recruitment of activated platelets to collagen but simultaneously increases platelet endothelial interactions in vitro.
    Calmer S; Ferkau A; Larmann J; Johanning K; Czaja E; Hagl C; Echtermeyer F; Goudeva L; Heuft HG; Theilmeier G
    Platelets; 2014; 25(1):8-15. PubMed ID: 23534885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Utility of desmopressin in 4 cases of thrombocytopathies associated with giant platelets].
    Martínez-Murillo C; Quintana-González S; Ambriz-Fernández R; Arzate-Hernández G; Gutiérrez-Romero M; Gaminio-Gómez E
    Rev Invest Clin; 1997; 49(4):281-6. PubMed ID: 9707993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of desmopressin (DDAVP) on blood platelet parameters in vivo and in vitro].
    Kätzel R; Dietzel H; Selle B; Taube C
    Z Gesamte Inn Med; 1992 Jul; 47(7):303-7. PubMed ID: 1496839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet aggregation induced by DDAVP in platelet-type von Willebrand's disease.
    Takahashi H; Nagayama R; Hattori A; Shibata A
    N Engl J Med; 1984 Mar; 310(11):722-3. PubMed ID: 6608051
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of a microfluidic flow assay to screen for von Willebrand disease and low von Willebrand factor levels.
    Lehmann M; Ashworth K; Manco-Johnson M; Di Paola J; Neeves KB; Ng CJ
    J Thromb Haemost; 2018 Jan; 16(1):104-115. PubMed ID: 29064615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Properties of the factor VIII after DDAVP (1-deamino-8-D-arginine vasopressin) infusion in normal subjects.
    Takahashi H; Itoh M; Kobayashi I; Sakuragawa N; Shibata A
    Tohoku J Exp Med; 1980 Oct; 132(2):133-40. PubMed ID: 6777902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laboratory response to intranasal desmopressin in women with menorrhagia and platelet dysfunction.
    Rose SS; Faiz A; Miller CH; Saidi P; Philipp CS
    Haemophilia; 2008 May; 14(3):571-8. PubMed ID: 18312366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet aggregation at high shear is impaired in patients with congenital defects of platelet secretion and is corrected by DDAVP: correlation with the bleeding time.
    Cattaneo M; Pareti FI; Zighetti M; Lecchi A; Lombardi R; Mannucci PM
    J Lab Clin Med; 1995 Apr; 125(4):540-7. PubMed ID: 7706911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shortening of bleeding time by 1-deamino-8-D-arginine vasopressin in various bleeding disorders.
    Kobrinsky NL; Israels ED; Gerrard JM; Cheang MS; Watson CM; Bishop AJ; Schroeder ML
    Lancet; 1984 May; 1(8387):1145-8. PubMed ID: 6144876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-treatment of porcine pulmonary xenograft with desmopressin: a novel strategy to attenuate platelet activation and systemic intravascular coagulation in an ex-vivo model of swine-to-human pulmonary xenotransplantation.
    Kim YT; Lee HJ; Lee SW; Kim JY; Wi HC; Park SJ; Bae SJ; Kang HJ
    Xenotransplantation; 2008 Feb; 15(1):27-35. PubMed ID: 18333911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Shortening of acetylsalicylic acid-prolonged bleeding time by means of desmopressin].
    Beck KH; Bleckmann U; Mohr P; Kretschmer V; Huss B
    Beitr Infusionsther Transfusionsmed; 1994; 32():437-9. PubMed ID: 9480140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.
    Michiels JJ; van de Velde A; van Vliet HH; van der Planken M; Schroyens W; Berneman Z
    Semin Thromb Hemost; 2002 Apr; 28(2):111-32. PubMed ID: 11992235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-treatment of donor with 1-deamino-8-d-arginine vasopressin could alleviate early failure of porcine xenograft in a cobra venom factor treated canine recipient.
    Kang HJ; Lee G; Kim JY; Lee SH; Wi HC; Hwang PG; Chung DH; Kim YT
    Eur J Cardiothorac Surg; 2005 Jul; 28(1):149-56. PubMed ID: 15982598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bleeding time prolongation with streptokinase and its reduction with 1-desamino-8-D-arginine vasopressin.
    Johnstone MT; Andrews T; Ware JA; Rudd MA; George D; Weinstein M; Loscalzo J
    Circulation; 1990 Dec; 82(6):2142-51. PubMed ID: 2242538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.